Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

13. März 2023 08:00 ET | Quelle: ProPhase Labs, Inc.

ProPhase Labs Announces Data Presentation for its BE-Smart Esophageal Cancer Test

Presentation to be given in Collaboration with the Mayo Clinic at the United States and Canadian Academy of Pathology (USCAP) Annual Meeting Company’s findings to be presented in a headline Poster...
08. November 2022 08:00 ET | Quelle: ProPhase Labs, Inc.

ProPhase Labs Announces Collaboration with Dana-Farber Cancer Institute

GARDEN CITY, NY, Nov. 08, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a growth oriented and diversified diagnostics, genomics and biotech company, today announced that its wholly...
26. Juli 2022 08:00 ET | Quelle: ProPhase Labs, Inc.

ProPhase Labs Announces New $6 Million Stock Repurchase Plan

Company also provides additional information on ProPhase BioPharma Garden City, NY, July 26, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a rapidly growing and...
28. Juni 2022 08:30 ET | Quelle: ProPhase Labs, Inc.

ProPhase Labs Announces Formation of ProPhase BioPharma, Inc. (PBIO) for the Licensing and Development of Novel Drugs, Compounds and Biotechnology

Company Also Announces First Licensing Agreement for PBIO with Global BioLife, Inc. for broad based Anti-Viral Fighting Compounds Equivir and Equivir G Garden City, NY, June 28, 2022 (GLOBE...